All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

Accuray Asia Ltd. and a subsidiary of China Isotope and Radiation Corp. (CIRC) have formed a joint venture (JV) to manufacture and sell radiation oncology systems in China. Joshua Levine, president and CEO of Sunnyvale, Calif.-based Accuray Inc., noted that the JV's unveiling followed an 18-month evaluation process. "We believe that . . . the JV will be ideally positioned to effectively address unmet patient needs and improve lives in the world's largest market for radiation oncology."